JTEC CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,000 JPY | -1.62% |
|
+1.47% | +5.54% |
| Sales 2024 * | 2.65B 17.03M | Sales 2025 * | 3.44B 22.11M | Capitalization | 11.95B 76.82M |
|---|---|---|---|---|---|
| Net income 2024 * | 390M 2.51M | Net income 2025 * | 540M 3.47M | EV / Sales 2024 * | 4.51 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.47 x |
| P/E ratio 2024 * |
30.8
x | P/E ratio 2025 * |
21.9
x | Employees | 64 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 49.52% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.62% | ||
| 1 week | +1.47% | ||
| Current month | -1.09% | ||
| 1 month | +2.41% | ||
| 3 months | -13.83% | ||
| 6 months | -5.03% | ||
| Current year | +5.54% |
1 week
1 900.00
2 090.00
1 month
1 900.002 180.00
Current year
1 875.002 468.00
1 year
1 731.002 920.00
3 years
1 342.004 025.00
5 years
1 342.005 000.00
10 years
1 342.0013 490.00
| Managers | Title | Age | Since |
|---|---|---|---|
Hisashi Tsumura
FOU | Founder | 67 | 93-12-20 |
Tetsuya Hidani
ADM | Chief Administrative Officer | - | - |
| Director/Board Member | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yoshio Matsumi
BRD | Director/Board Member | 77 | 18-08-31 |
Hisashi Tsumura
FOU | Founder | 67 | 93-12-20 |
Hiromi Okada
BRD | Director/Board Member | 54 | 04-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.02% | 14 M€ | +15.01% | ||
| 0.00% | 144,586 M€ | +13.76% | ||
| 0.00% | 66,066 M€ | +13.80% | - | |
| 0.00% | 20,721 M€ | +12.65% | - | |
| 0.00% | 18 M€ | +16.15% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 2,000 | -1.62% | 26 900 |
| 24-04-24 | 2,033 | -2.26% | 33,900 |
| 24-04-23 | 2,080 | +4.31% | 77,400 |
| 24-04-22 | 1,994 | +1.84% | 32,100 |
| 24-04-19 | 1,958 | -0.66% | 54,400 |
Delayed Quote Japan Exchange, April 25, 2024 at 02:00 am EDT
More quotes
JTEC Corp mainly manufactures and sells medical-related systems. The Company operates through two business segments. The main products of the Optical segment are X-ray nano-collecting mirrors for synchrotron radiation and X-ray free electron laser facilities. This segment is engaged in the manufacture and sale of special mirrors focusing on X-ray nano-collecting mirrors used for advanced analyzers for a wide range of research including basic research and industrial applications. The main products of the Life Science and Equipment Development segment are various automatic cell culture devices and other automation devices. This segment develops, sells various automatic cell culture devices. In addition to medical and biotechnology fields, it develops, manufactures and sells outsourced products and proprietary products to research institutes and companies in various fields.
Calendar
2024-05-13
- Q3 2024 Earnings Release
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +5.54% | 77.08M | |
| -2.89% | 185B | |
| -2.43% | 107B | |
| -4.10% | 67.55B | |
| +11.10% | 54.6B | |
| +15.86% | 47.42B | |
| +3.86% | 42.24B | |
| +9.55% | 28.24B | |
| +1.85% | 26.42B | |
| +12.40% | 25.66B |
- Stock Market
- Equities
- 3446 Stock
